Powered by

Neuronal Acetylcholine Receptor Subunit Beta 2, Pipeline Review, H2 2019: Assuage Pharmaceuticals Inc & Kyung Dong Co. Ltd - ResearchAndMarkets.com

Jan 16, 2020 - Business Wire

The "Neuronal Acetylcholine Receptor Subunit Beta 2 - Pipeline Review, H2 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Summary

According to the recently published report 'Neuronal Acetylcholine Receptor Subunit Beta 2 - Pipeline Review, H2 2019'; Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) pipeline Target constitutes close to 9 molecules. Out of which approximately 8 molecules are developed by companies and remaining by the universities/instit...